Variable | Â |
---|---|
Scoring on ICU admission | |
 SOFA score | 6 (3, 7) |
 APACHE-II score | 17 (13, 19) |
 SAPS-II score | 31 (21, 38) |
ICU therapy | |
  Invasive mechanical ventilation | 17 (71) |
  Days of illness on intubation*, days | 11 (10, 12) |
  Nadir PaO2/FIO2 ratio* | 169 (108, 183) |
  Maximum positive end-expiratory pressure* | 12 (10, 12) |
  Prone positioning* | 4 (24) |
  Neuromuscular blockade* | 2 (12) |
  Extracorporeal membrane oxygenation* | 1 (6) |
 Inhaled nitrate oxide* | 1 (6) |
  Tracheostomy* | 4 (24) |
 Vasopressors | 15 (63) |
 Renal replacement therapy | 2 (8) |
 Enteral feeding within 24 h of ICU admission | 16 (67) |
 Enteral feeding within 48 h of ICU admission | 19 (79) |
Pharmaceutical Treatments | |
 Systemic steroids | |
  High-dose methylprednisolone | 16 (67) |
  Low-dose methylprednisolone | 5 (21) |
  No systemic steroid | 3 (13) |
 Antiviral agents | |
  Favipiravir | 9 (38) |
  Lopinavir/Ritonavir | 4 (17) |
 Antibacterial agents†| |
  Piperacillin/Tazobactam and Azithromycin | 7 (29) |
  Piperacillin/Tazobactam and Levofloxacin | 4 (17) |
  Ceftriaxone and Azithromycin | 10 (42) |
  Ceftriaxone and Levofloxacin | 1 (4) |
  Ceftriaxone and Minocycline | 1 (4) |
  Ampicillin/Sulbactam and Azithromycin | 1 (4) |
 Anticoagulants | |
  Subcutaneous bolus injection of unfractionated heparin | 6 (25) |
  Intravenous continuous unfractionated heparin | 12 (50) |
  No anticoagulant | 6 (25) |